Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Morgan Keegan Reduces Cost Plus to Underperform


Morgan Keegan downgraded Cost Plus (CPWM) to underperform from market perform, citing a lower outlook for earnings.

Analyst Laura Champine says first quarter guidance of 8 cents to 16 cents loss was below the former 8 cents earnings per share (EPS) estimate. Its 86 cents to $1.03 fiscal year 2007 (ending Jan) EPS guidance (including 14 cents in stock based compensation expense) was below the $1.34 estimate. As such, the analyst cuts a first quarter estimate to 12 cents loss, and a fiscal year 2007 EPS estimate to 95 cents, with a 14 cents EPS of fiscal year 2007 estimate reduction due to the inclusion of stock-compensation expense. The analyst recommends that investors sell shares, based on valuation, and reduced earnings outlook.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus